文献速递肿瘤 PET/CT

头颈部肿瘤血管生成显像:68Ga-NODAGA-RGD与18F-FDG PET/CT对比的先导研究

Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study.
PubMed 文献 · EJNMMI Res · 2020-05-07

这项先导研究前瞻性纳入10例患者共11个头颈部鳞状细胞癌(HNSCC),比较68Ga-NODAGA-RGD PET/CT(显像αvβ3整合素)与18F-FDG PET/CT的分布。两种示踪剂均能显示所有肿瘤,18F-FDG的SUVmax和SUVmean均高于68Ga-NODAGA-RGD,但68Ga-NODAGA-RGD的空间分布与18F-FDG不同,提供不同的肿瘤信息。

要点

  • 10例患者共11个HNSCC,两种示踪剂均能检出全部肿瘤。
  • 18F-FDG SUVmax 14.0±6.1 vs 68Ga-NODAGA-RGD 3.9±1.1 g/mL(p=0.0017)。
  • 两种示踪剂摄取与分级、HPV状态、p16表达均无相关性(p≥0.17)。

核心结论

  • 所有HNSCC肿瘤均可被两种示踪剂检出,但18F-FDG摄取更高;68Ga-NODAGA-RGD的空间分布与18F-FDG不同,提供不同的肿瘤信息。

研究设计与样本

  • 前瞻性先导研究,纳入10例患者(年龄58.4±8.3岁,范围44-73岁,男6例、女4例),共11个HNSCC。
  • 对原发肿瘤记录68Ga-NODAGA-RGD与18F-FDG PET/CT的放射性分布图和标准化摄取值(SUV),采用Wilcoxon符号秩检验比较,采用Spearman相关评估两种示踪剂SUV间的关系。

主要发现

  • 所有HNSCC肿瘤在两种示踪剂显像中均可见。
  • 18F-FDG SUVmax为14.0±6.1 g/mL,高于68Ga-NODAGA-RGD的3.9±1.1 g/mL(p=0.0017)。
  • 18F-FDG SUVmean为8.2±3.1 g/mL,高于68Ga-NODAGA-RGD的2.0±0.8 g/mL(p=0.0017)。
  • 18F-FDG与68Ga-NODAGA-RGD摄取均与分级、HPV状态及p16蛋白表达无相关性(p≥0.17)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiogenesis plays an important role in head and neck squamous cell carcinoma (HNSCC) progression. This pilot study was designed to compare the distribution of 68Ga-NODAGA-RGD PET/CT for imaging αvβ3 integrins involved in tumor angiogenesis to 18F-FDG PET/CT in patients with HNSCC. MATERIAL AND METHODS: Ten patients (aged 58.4 ± 8.3 years [range, 44-73 years], 6 males, 4 females) with a total of 11 HNSCC were prospectively enrolled. Activity mapping and standard uptake values (SUV) from both 68Ga-NODAGA-RGD and 18F-FDG PET/CT scans were recorded for primary tumor and compared with the Wilcoxon signed-rank test. The relation between the SUV of both tracers was assessed using the Spearman correlation. RESULTS: All HNSCC tumors were visible with both tracers. Quantitative analysis showed higher 18F-FDG SUVmax in comparison to 68Ga-NODAGA-RGD (14.0 ± 6.1 versus 3.9 ± 1.1 g/mL, p = 0.0017) and SUVmean (8.2 ± 3.1 versus 2.0 ± 0.8 g/mL, p = 0.0017). Both 18F-FDG and 68Ga-NODAGA-RGD uptakes were neither correlated with grade, HPV status nor p16 protein expression (p ≥ 0.17). CONCLUSION: All HNSCC tumors were detected with both tracers with higher uptake with 18F-FDG, however. 68Ga-NODAGA-RGD has a different spatial distribution than 18F-FDG bringing different tumor information. TRIAL REGISTRATION: NCT, NCT02666547. Registered 12.8.2012.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Durante S, Dunet V, Gorostidi F, et al. Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study. EJNMMI Res. 2020. PMID: 32382869. doi:10.1186/s13550-020-00638-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。